David J. Nutt

Drink?

co trzeba wiedzieć o legalnych i nielegalnych substancjach psychoaktywnych

Narkotyki bez paniki

Clare Short

Caroline Bell

Christine Masterson

Psychopharmacological treatment of children and adolescents is a rapidly evolving field. It has become clear that a "psychopharmacological way of thinking" provides a useful model for explaining the nature of disorders to children and their families. For the clinician, a similar approach helps explain why, when, what and how to proscribe more logical. This concise book covers all the recent advances, our current state of understanding of the neurobiological processes underlying these conditions and the various treatment options. When the psychopharmacology and neurochemistry involved are understood, the choice of drug or therapy for each child is less daunting. Treatment can be tailored to specific symptoms and disease profiles, with side effects anticipated and explained. This book provides the information clinicians need to make informed choices in this complex field.

A Psychopharmacological Approach

Mood and Anxiety Disorders in Children and Adolescents

James C. Ballenger

Rapid developments in recent years in basic science and pharmacology has greatly increased understanding of the causes of anxiety disorders. This has led to a large number of new drug treatments from the pharmaceutical industry. This book makes sense of these advances and presents a coherent account of diagnosis and management from the clinical point of view. Chapters are in the form of surveys and digests of the recent literature and are interspersed with clinical guidelines, diagnostic and therapeutic points and are well illustrated.

Anxiety Disorders

Trevor W. Robbins

Barry J. Everitt

In the past two decades, there have been astonishing advances in our understanding of the neurobiological basis and nature of drug addiction. We now know the initial molecular sites of action, at identified receptors, of virtually all of the major drugs of abuse including cocaine, heroin, and amphetamine, as well as legal drugs such as nicotine and alcohol. We also understand the main components of a 'reward system' and its connections to major brain regions involved in motivation and emotion, such as the amygdala, hippocampus, and prefrontal cortex. The Neurobiology of Addiction describes the latest advances in our understanding of addiction. It brings together world class researchers to debate the nature and extent of addiction, as well as its causes, consequences, and treatment. The focus of the book is on the brain processes underlying addiction, in terms of neural systems, neurochemical basis, and molecular changes. Several types of addiction are discussed ranging from illicit drugs - cocaine, amphetamine, and heroin to legal drugs - alcohol and nicotine. In addition, it explores increasingly common behavioural addictions such as gambling and obesity. Included are chapters on vulnerability to addiction, genetic factors, opponent motivational processes, animal models, relapse, cognitive deficits associated with drug abuse, new pharmacological treatments, and current controversies concerning different neuropsychological theories of addiction. Throughout, it reports on cutting edge research using brain imaging, and state of the art molecular methodology. The book will make fascinating reading for students and teachers in the field of neuroscience, pharmacology and psychology, as well as experts in the field.

New Vistas

The Neurobiology of Addiction

Michael E. Thase

Raymond W. Lam

Willis H. Thomas

For some organizations, Lessons Learned (LL) is an informal process of discussing and recording project experiences during the closure phase. For others, LL is a formal process that occurs at the end of each phase of a project. Regardless of when they are performed, if you are a project team member, chances are you will soon be required to present

The Basics of Project Evaluation and Lessons Learned

S. R. Pandi-Perumal

Jaime M. Monti

Barry L. Jacobs

This book focuses on the neuropsychopharmacology of serotonin and its role in sleep and wakefulness, presenting neurochemical, electrophysiological, and neuropharmacological approaches to understand the mechanisms of serotonin and related substances. Covering core and contemporary topics in the area, this volume is valuable for all researchers interested in interdisciplinary studies concerning drugs affecting the central nervous system.

Serotonin and Sleep: Molecular, Functional and Clinical Aspects

Peter M. Haddad

This greatly expanded third edition provides a comprehensive overview of clinical psychopharmacology, incorporating the major advances in the field since the previous edition's publication. Renowned experts from psychiatry, pharmacy, and nursing have integrated basic science, psychopharmacology, and clinical practice throughout the book in order to provide a thorough basis for prescribing. It covers all key psychiatric drugs and disorders and includes the latest data on efficacy, safety and tolerability. Adopting a pragmatic approach to drug nomenclature, both Neuroscience-based Nomenclature (NbN) and older generic terminology are included in the text reflecting that clinicians are likely to use both systems. Many chapters refer to current National Institute of Health and Care Excellence (NICE) guidelines, making this a crucial resource. Edited by leading authorities in the field, Professor Peter M. Haddad and Professor David J. Nutt, Seminars in Clinical Psychopharmacology emphasises evidence-based prescribing with the aim of achieving better clinical outcomes for patients.

Seminars in Clinical Psychopharmacology

Andrew Jackson

Gerald V. Stimson

Martin Ince

Drugs and the Future presents 13 reviews collected to present the new advances in all areas of addiction research, including knowledge gained from mapping the human genome, the improved understanding of brain pathways and functions that are stimulated by addictive drugs, experimental and clinical psychology approaches to addiction and treatment, as well as both ethical considerations and social policy. The book also includes chapters on the history of addictive substances and some personal narratives of addiction. Introduced by Sir David King, Science Advisory to the UK Government and head of the Office of Science and Technology, and Nora Volkow, director of the National Institute on Drug Abuse in the USA, the book uniquely covers the full range of disciplines which can provide insight into the future of addiction, from genetics to the humanities. Written for a scientific audience, it is also applicable to non-specialists as well. Provides an unique overview of what we know about addiction, and how scientific knowledge can and should be applied in the societal, ethical, and political context Applies the state-of-the-art research in fields such as Genomics, Neuroscience, Pharmacology, Social Policy and Ethics to addiction research Includes a preface by Sir David King, Science Advisory to the UK Government and head of the Office of Science and Technology, and in introduction by Nora Volkow, director of the National Institute on Drug Abuse in the USA

Brain Science, Addiction and Society

Drugs and the Future

David J. Nutt

Books

Your next favorite book is out there